TP53 and ovarian carcinoma: We selected three human HGSOC cell lines (OVCAR3, OVCAR4, OVCAR8) and two patient-derived chemo-naïve cell lines from the Australian Ovarian Cancer Study (AOCS14, AOCS30) encompassing a range of different genetic backgrounds in addition to their known mutations in TP53 [3, 26].